Published in RNA on April 01, 2010
MicroRNAs in human cancer. Adv Exp Med Biol (2013) 3.19
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol (2010) 2.20
Identification and remediation of biases in the activity of RNA ligases in small-RNA deep sequencing. Nucleic Acids Res (2011) 2.01
Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res (2013) 1.82
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer (2011) 1.77
Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One (2012) 1.76
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology (2012) 1.62
Comprehensive survey of human brain microRNA by deep sequencing. BMC Genomics (2010) 1.59
Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One (2012) 1.52
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One (2011) 1.49
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J Clin Med (2015) 1.48
MicroRNA profiling: separating signal from noise. Nat Methods (2010) 1.45
Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40
Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics (2011) 1.39
Bacteria-responsive microRNAs regulate plant innate immunity by modulating plant hormone networks. Plant Mol Biol (2010) 1.38
Identifying miRNAs, targets and functions. Brief Bioinform (2012) 1.35
Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med (2014) 1.34
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. Br J Cancer (2012) 1.27
miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet (2014) 1.25
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues. PLoS One (2013) 1.24
A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis (2013) 1.18
Analysis of Litopenaeus vannamei transcriptome using the next-generation DNA sequencing technique. PLoS One (2012) 1.16
MicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus. PLoS One (2011) 1.16
CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data. BMC Genomics (2014) 1.15
Effect of life history on microRNA expression during C. elegans development. RNA (2011) 1.11
Genome-wide identification of miRNAs responsive to drought in peach (Prunus persica) by high-throughput deep sequencing. PLoS One (2012) 1.10
Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma. J Transl Med (2014) 1.09
Profiling of circulating microRNAs after a bout of acute resistance exercise in humans. PLoS One (2013) 1.08
Challenges in using circulating miRNAs as cancer biomarkers. Biomed Res Int (2015) 1.08
Characterization of the stress associated microRNAs in Glycine max by deep sequencing. BMC Plant Biol (2011) 1.08
MicroRNAs as lung cancer biomarkers. World J Clin Oncol (2014) 1.07
The molecular landscape of premenopausal breast cancer. Breast Cancer Res (2015) 1.03
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles (2015) 1.02
Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab (2011) 1.01
MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Cancer Biol Ther (2013) 1.01
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One (2012) 1.01
Analysis of rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected rhesus macaques. Virology (2010) 1.00
MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. BMC Infect Dis (2013) 1.00
Assessing an improved protocol for plasma microRNA extraction. PLoS One (2013) 1.00
Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp Neurol (2012) 0.99
miR-ID: a novel, circularization-based platform for detection of microRNAs. RNA (2010) 0.99
Global analysis reveals multiple pathways for unique regulation of mRNA decay in induced pluripotent stem cells. Genome Res (2012) 0.98
Salivary microRNAs and oral cancer detection. Methods Mol Biol (2013) 0.98
Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform (2015) 0.98
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol (2013) 0.97
Analysis options for high-throughput sequencing in miRNA expression profiling. BMC Res Notes (2014) 0.96
Differences in microRNA detection levels are technology and sequence dependent. RNA (2013) 0.93
Conjunctival MicroRNA expression in inflammatory trachomatous scarring. PLoS Negl Trop Dis (2013) 0.93
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis (2013) 0.92
Comparability and reproducibility of biomedical data. Brief Bioinform (2012) 0.92
Characterization of the small RNA component of leaves and fruits from four different cucurbit species. BMC Genomics (2012) 0.92
MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. Front Cell Neurosci (2014) 0.91
Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics (2014) 0.91
High-throughput sequencing reveals differential expression of miRNAs in intestine from sea cucumber during aestivation. PLoS One (2013) 0.90
Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine. Biomicrofluidics (2016) 0.90
Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC Musculoskelet Disord (2010) 0.90
Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues. Oncoscience (2015) 0.89
microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther (2015) 0.89
MicroRNAs as effectors of brain function. Stroke (2013) 0.88
Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One (2012) 0.88
A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients. Sci Rep (2015) 0.88
Transcriptome-wide identification and characterization of microRNAs from castor bean (Ricinus communis L.). PLoS One (2013) 0.88
Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows. PLoS One (2013) 0.88
Convergent transcription induces dynamic DNA methylation at disiRNA loci. PLoS Genet (2013) 0.88
Characterization of microRNA expression profiles in Leishmania-infected human phagocytes. Parasite Immunol (2015) 0.88
Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine? Expert Rev Mol Diagn (2014) 0.87
An integrated nano-scale approach to profile miRNAs in limited clinical samples. Am J Clin Exp Immunol (2012) 0.87
Expression of miR-15/107 family microRNAs in human tissues and cultured rat brain cells. Genomics Proteomics Bioinformatics (2014) 0.86
Unraveling genomic variation from next generation sequencing data. BioData Min (2013) 0.86
SEAS: a system for SEED-based pathway enrichment analysis. PLoS One (2011) 0.86
Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol (2013) 0.86
Discovery of novel microRNAs in rat kidney using next generation sequencing and microarray validation. PLoS One (2012) 0.86
DNA Nanostructure-based Interfacial engineering for PCR-free ultrasensitive electrochemical analysis of microRNA. Sci Rep (2012) 0.86
Expression of microRNAs in the NCI-60 cancer cell-lines. PLoS One (2012) 0.86
Genome-wide identification and comparative analysis of conserved and novel microRNAs in grafted watermelon by high-throughput sequencing. PLoS One (2013) 0.86
Mechanisms of small RNA generation from cis-NATs in response to environmental and developmental cues. Mol Plant (2013) 0.86
Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection. Gut Liver (2015) 0.85
Convergent microRNA actions coordinate neocortical development. Cell Mol Life Sci (2014) 0.85
Investigation of the microRNAs in safflower seed, leaf, and petal by high-throughput sequencing. Planta (2010) 0.85
Determination of reliable reference genes for multi-generational gene expression analysis on C. elegans exposed to abused drug nicotine. Psychopharmacology (Berl) (2013) 0.84
Elimination of ligation dependent artifacts in T4 RNA ligase to achieve high efficiency and low bias microRNA capture. PLoS One (2014) 0.84
Universal digital high-resolution melt: a novel approach to broad-based profiling of heterogeneous biological samples. Nucleic Acids Res (2013) 0.84
Epigenetic biomarkers in skin cancer. Cancer Lett (2012) 0.84
Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines. PLoS One (2013) 0.84
An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells. BMC Genomics (2012) 0.84
Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study. J Transl Med (2013) 0.83
A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice. PLoS One (2013) 0.83
Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR. J Am Heart Assoc (2014) 0.83
miRNA regulation of cytotoxic effects in mouse Sertoli cells exposed to nonylphenol. Reprod Biol Endocrinol (2011) 0.83
N6-adenosine methylation in MiRNAs. PLoS One (2015) 0.83
FANSe2: a robust and cost-efficient alignment tool for quantitative next-generation sequencing applications. PLoS One (2014) 0.83
A wholly defined Agilent microarray spike-in dataset. Bioinformatics (2011) 0.82
Circumventing qPCR inhibition to amplify miRNAs in plasma. Biomark Res (2014) 0.82
Label-free high-throughput microRNA expression profiling from total RNA. Nucleic Acids Res (2011) 0.82
Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion. Oncol Lett (2014) 0.82
A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma. BMC Cancer (2015) 0.81
Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples. Gigascience (2015) 0.81
miR-30 family microRNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway. PLoS One (2015) 0.81
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs. J Vis Exp (2015) 0.80
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. Oncotarget (2016) 0.80
SSAHA: a fast search method for large DNA databases. Genome Res (2001) 48.64
Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44
miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
Identification of virus-encoded microRNAs. Science (2004) 12.56
Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol (2008) 12.35
A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64
miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res (2008) 6.30
The let-7 family of microRNAs. Trends Cell Biol (2008) 6.24
Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods (2008) 6.22
Facile means for quantifying microRNA expression by real-time PCR. Biotechniques (2005) 5.04
miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res (2006) 4.91
Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods (2009) 4.34
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res (2008) 4.08
Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA (2007) 3.91
WU-Blast2 server at the European Bioinformatics Institute. Nucleic Acids Res (2003) 3.82
Direct and sensitive miRNA profiling from low-input total RNA. RNA (2006) 3.17
An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA (2005) 3.12
MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab (2006) 2.84
miRNAs and apoptosis: RNAs to die for. Oncogene (2006) 2.80
microRNAs and cancer: an overview. Cell Cycle (2008) 2.80
Impact of normalization on miRNA microarray expression profiling. RNA (2009) 2.63
Control of cell proliferation pathways by microRNAs. Cell Cycle (2008) 2.33
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics (2008) 2.11
Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One (2009) 2.02
Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Rev Mol Med (2008) 1.99
Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. RNA (2009) 1.96
Absolute quantification of microRNAs by using a universal reference. RNA (2009) 1.79
Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol (2008) 1.75
Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res (2008) 1.54
Comparison of normalization methods with microRNA microarray. Genomics (2008) 1.51
Profiling microRNA expression with microarrays. Trends Biotechnol (2008) 1.48
MicroRNA detection by microarray. Anal Bioanal Chem (2009) 1.40
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. J Natl Cancer Inst (1983) 1.29
Empirical evaluation of a new method for calculating signal-to-noise ratio for microarray data analysis. Appl Environ Microbiol (2008) 1.27
Mammalian microRNA prediction through a support vector machine model of sequence and structure. PLoS One (2007) 1.20
RISC-target interaction: cleavage and translational suppression. Biochim Biophys Acta (2008) 1.18
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
MicroRNAs and micromanaging the skeleton in disease, development and evolution. J Cell Mol Med (2009) 1.08
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes. Breast Cancer Res (2008) 1.04
Thinking about RNA? MicroRNAs in the brain. Mamm Genome (2008) 0.98
Signatures of mutational processes in human cancer. Nature (2013) 21.63
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47
International network of cancer genome projects. Nature (2010) 20.35
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med (2013) 13.22
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet (2005) 8.45
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature (2013) 7.42
Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science (2010) 7.41
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature (2012) 7.00
The transcriptional activity of human Chromosome 22. Genes Dev (2003) 6.82
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature (2012) 5.84
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med (2012) 5.69
Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol (2005) 5.63
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol (2010) 5.23
The evolutionary landscape of alternative splicing in vertebrate species. Science (2012) 4.78
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol (2007) 4.70
ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods (2009) 4.69
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol (2007) 4.33
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell (2003) 4.33
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer (2007) 4.06
Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A (2003) 3.89
An integrated approach for finding overlooked genes in yeast. Nat Biotechnol (2002) 3.88
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol (2008) 3.49
Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell (2012) 3.48
Complex transcriptional circuitry at the G1/S transition in Saccharomyces cerevisiae. Genes Dev (2002) 3.27
Multi-species microarrays reveal the effect of sequence divergence on gene expression profiles. Genome Res (2005) 3.23
Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell (2008) 3.18
MicroRNA: implications for cancer. Virchows Arch (2007) 3.17
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet (2010) 3.15
p300/CBP and cancer. Oncogene (2004) 3.13
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J (2011) 2.97
Systematic evaluation of spliced alignment programs for RNA-seq data. Nat Methods (2013) 2.92
Molecular fossils in the human genome: identification and analysis of the pseudogenes in chromosomes 21 and 22. Genome Res (2002) 2.89
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell (2008) 2.87
Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet (2012) 2.80
The implications of clonal genome evolution for cancer medicine. N Engl J Med (2013) 2.78
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping. Cancer Genet Cytogenet (2005) 2.70
PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics (2010) 2.65
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet (2013) 2.63
Towards practical, high-capacity, low-maintenance information storage in synthesized DNA. Nature (2013) 2.56
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med (2012) 2.55
A Ca2+/calmodulin-dependent protein kinase required for symbiotic nodule development: Gene identification by transcript-based cloning. Proc Natl Acad Sci U S A (2004) 2.54
Sizing up miRNAs as cancer genes. Nat Med (2005) 2.48
Target hub proteins serve as master regulators of development in yeast. Genes Dev (2006) 2.39
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology (2003) 2.39
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep (2013) 2.37
Issues in the analysis of oligonucleotide tiling microarrays for transcript mapping. Trends Genet (2005) 2.36
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci Transl Med (2013) 2.34
CREB binds to multiple loci on human chromosome 22. Mol Cell Biol (2004) 2.28
Molecular characterization of geminivirus-derived small RNAs in different plant species. Nucleic Acids Res (2006) 2.26
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res (2014) 2.25
The shaping and functional consequences of the microRNA landscape in breast cancer. Nature (2013) 2.22
Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Breast Cancer Res (2012) 2.18
A consensus prognostic gene expression classifier for ER positive breast cancer. Genome Biol (2006) 2.17
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin Cancer Res (2006) 2.16
NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell (2012) 2.15
PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer. Bioinformatics (2006) 2.12
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer (2008) 2.11
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res (2008) 2.09
NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J (2011) 2.09
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med (2011) 2.07
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene (2005) 2.05
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell (2007) 2.05
Human and mouse oligonucleotide-based array CGH. Nucleic Acids Res (2005) 2.03
Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev (2005) 2.01
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601). Lancet Oncol (2010) 2.01
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res (2012) 1.95
Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc (2013) 1.91
Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet (2011) 1.91
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes Dev (2013) 1.88
HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics (2009) 1.87
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer (2008) 1.76
Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med (2005) 1.76
Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics (2012) 1.74
Cancer genetics of epigenetic genes. Hum Mol Genet (2007) 1.72
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res (2006) 1.71
The wound response in tomato--role of jasmonic acid. J Plant Physiol (2005) 1.68
ExpressYourself: A modular platform for processing and visualizing microarray data. Nucleic Acids Res (2003) 1.68
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas. J Pathol (2010) 1.68
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates. Elife (2013) 1.63
Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer (2005) 1.62
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol (2004) 1.59
The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics (2009) 1.55